STOCK TITAN

Surgalign Holdings, Inc. - $SRGAQ STOCK NEWS

Welcome to our dedicated page for Surgalign Holdings news (Ticker: $SRGAQ), a resource for investors and traders seeking the latest updates and insights on Surgalign Holdings stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Surgalign Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Surgalign Holdings's position in the market.

Rhea-AI Summary
Surgalign Holdings has announced the selection of Xtant Medical Holdings and Augmedics as successful bidders for its assets. Xtant will acquire the hardware and biologics assets for a cash purchase price of $5 million, while Augmedics will acquire the digital health assets for $900,000. The bids will help Surgalign move forward with its chapter 11 plan and return value to stakeholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Surgalign Holdings, Inc.

OTC:SRGAQ

SRGAQ Rankings

SRGAQ Stock Data

165.30k
7.89M
11.81%
28.56%
0.72%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Deerfield

About SRGAQ

surgalign holdings, inc., a medical technology company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. it offers coflex interlaminar stabilization device, an implant for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; simmetry sacroiliac joint fusion system, which decreases in opioid use, pain, and disability; and fortilink ibf system with tetrafuse ?3d technology. the company's implants are used in the fields of orthopedic, spine, sports medicine, plastic surgery, trauma, and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. it markets its products through its direct distribution force and various oem relationships to healthcare providers, hospitals, and other healthcare facilities, as well as through a network of independent distributors. the company was founded in 1997 and is headquartered in dee